HomeAI · summaries
Storia in 6 fonti
Novartis pauses trials of experimental cell therapy after three deaths - Health - The Jakarta Post
The halt was implemented on August 24 after Novartis was notified of three cases of a severe, life-threatening immune reaction. Complications from the reaction, in which the body's defense system overreacts and attacks its own organs, led to the deaths, the Swiss drugmaker said.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
The deaths of three study participants led Novartis to halt development of rap-cel in multiple indications, while “transient” side effects pushed Bristol Myers to voluntarily…
- ·
endpoints.news
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Novartis halts CAR-T trials after three patient deaths from an immune overreaction; Bristol Myers pauses zola-cel enrollment.
